Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.

Subsidiary ofEMERGENT BIOSOLUTIONS INC.UEI: CNPVCR8DK7M8CAGE: 057Y1

EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. is a federal contractor, registered under UEI CNPVCR8DK7M8 and CAGE code 057Y1. It has been awarded $2,861,158,700 in federal contracts. Primary work spans Research and Development in Biotechnology, Biological Product (except Diagnostic) Manufacturing, and Research and Development in Biotechnology (except Nanobiotechnology). Top awarding agencies include Department Of Health And Human Services, Department Of Defense, and Other agencies (1 agencies, <0.5% each).

Contact Information

Registration and classification details

Registration

UEI Code

CNPVCR8DK7M8

CAGE Code

057Y1

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit OrganizationLimited Liability CompanyManufacturer of Goods

NAICS Codes

325412Pharmaceutical Preparation Manufacturing
541713Research and Development in Nanotechnology
541714Research and Development in Biotechnology (except Nanobiotechnology)(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Emergent Product Development Gaithersburg Inc. specializes in the advanced development and manufacturing of biological countermeasures, with deep expertise in biotechnology research, vaccine candidate optimization, and clinical-scale product development. The contractor delivers end-to-end solutions ...

Emergent Product Development Gaithersburg Inc. specializes in the advanced development and manufacturing of biological countermeasures, with deep expertise in biotechnology research, vaccine candidate optimization, and clinical-scale product development. The contractor delivers end-to-end solutions for medical countermeasures against high-consequence pathogens, including filoviruses and anthrax, leveraging proprietary platforms such as adjuvanted vaccine formulations and novel immunotherapeutic constructs. Their technical proficiency spans preclinical to late-stage development, including GMP manufacturing of biological products, clinical trial support, and regulatory-aligned process scaling, with a demonstrated focus on accelerating timelines for public health emergencies. The company maintains a sustained partnership with the Department of Health and Human Services, particularly through the Biomedical Advanced Research and Development Authority (BARDA), delivering critical R&D and manufacturing capabilities for national preparedness initiatives. Their work for HHS centers on advancing medical countermeasures under the Project BioShield framework, while a prior engagement with the Department of Defense involved clinical evaluation of analgesic therapeutics, indicating cross-agency adaptability in life sciences support. Emergent Product Development Gaithersburg Inc. operates primarily under NAICS codes 541711 and 541714, focusing on biotechnology R&D excluding nanobiotechnology, and 325414 for biological product manufacturing. This positions them as a niche provider of vaccine and therapeutic development services tailored to federal biodefense and pandemic response mandates, bridging the gap between discovery and deployable medical solutions. As a 2L entity based in Gaithersburg, Maryland, the company is strategically located within the National Capital Region’s biopharmaceutical corridor. While no government certifications are listed, their consistent engagement with BARDA and adherence to federal biological product standards reflect a mature, compliance-driven operational framework aligned with federal procurement expectations.

Key Performance Metrics

Awards Count

30

All time

Active

3

Currently performing

Completed

27

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Export
Awards by Agency Over Time
Awards by Place of Performance

Compete with EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.'s top NAICS codes and agencies

NAICS: 541330
New
Federal
AIR FORCE CRYPTOLOGIC OFFICE COMMERCIAL SOLUTIONS OPENING
Solicitation # FA7037-21-S-C001
The Air Force Cryptologic Office (AFCO) Cyberspace Intelligence Surveillance and Reconnaissance and Multi-Domain Innovation Division is soliciting innovative commercial capabilities through Commercial Solutions Opening FA7037-21-S-C001. The agency is seeking mature technologies and services in Electromagnetic Warfare, Information Operations, and electromagnetic digital communications, with a specific goal of achieving a field demonstration within one year. This solicitation emphasizes the use of novel material approaches and innovative services, including updated references to Super Intelligence. Awards may be issued as contracts or Other Transactions with periods of performance typically ranging from one to five years. The procurement follows a competitive two-phase submission process governed by 10 USC 3458 and DFARS 212.70. Phase I requires the submission of Quad Charts and White Papers, which are evaluated based on technical merit, importance to the AFCO mission, and fund availability. Selected offerors are then invited to Phase II to submit full technical and price proposals. All submissions are treated as commercial items. Offerors must possess the necessary personnel and facility security clearances to perform classified work in accordance with the National Industrial Security Program Operating Manual and DD Form 254. The primary point of contact for this effort is Carissa Heuertz.
Department Of Defense

POSTED

about 9 hours ago

DEADLINE

in 12 months
View Details
NAICS: 611430
New
Federal
Sources Sought / Intent to Sole Source
Solicitation # W91QV127RA006
The Department of Defense is seeking capability statements for a non-personal services contract to provide professional and management development training for the Office of Army Cemeteries and Army National Military Cemeteries. Classified under NAICS 611430, the requirement consists of six distinct soft skills training sessions to be delivered via a streaming format, such as MS Teams, for approximately 250 civilian and military personnel. The training schedule is firm, with courses running from December 1, 2026, through September 7, 2027, covering topics including emotional intelligence, workplace civility, conflict resolution, goal setting, workplace anxiety, and handling difficult conversations. The government currently intends to award a sole source purchase order to DrTinaTalksWork but is conducting market research to determine if other capable small businesses exist. To be considered, respondents must be accredited through the International Accreditors for Continuing Education and Training (IACET) and possess a Doctorate in Management and Organizational Leadership or an equivalent degree, along with prior Department of Defense affiliation. Interested parties must submit a capability statement of no more than five pages to the designated contract specialists by October 24, 2026, demonstrating their ability to meet all statement of work requirements and provide training on the exact dates requested.
Department Of Defense

POSTED

1 day ago

DEADLINE

in 9 days
View Details
NAICS: 236220
New
Federal
EIE485 Consolidated Munitions on Quarry Hill, Eielson AFB, AK
Solicitation # W911KB27RWP04
The U.S. Army Corps of Engineers, Alaska District, is conducting market research for project EIE485, which involves the consolidation of munitions storage functions at Eielson Air Force Base, Alaska. The project scope includes the design and construction of new munitions storage facilities at Quarry Hill, including a warm storage vehicle facility, and the demolition and debris removal of 12 existing facilities at Engineer Hill. All designs must strictly adhere to Air Force Standard Designs, specifically Defense Explosives Safety Regulation 6055.09 and Air Force Manual AFMAN 91-01 Explosives Safety Standards. The target budget for this effort is approximately 196.4 million dollars. The anticipated period of performance spans from fiscal year 2027 to 2031, with design work beginning in FY27 and construction starting no earlier than FY29. The government is currently evaluating the most effective project delivery method and contracting vehicle, considering options such as Accelerated Design-Build to Budget via a FAR-based approach or Other Transaction Authority vehicles like Construction Manager at Risk or Progressive Design-Build. Key project challenges identified for industry feedback include site constraints such as permafrost and PFAS. The government is seeking input from a wide range of socioeconomic business categories to determine the optimal acquisition strategy and evaluation criteria, focusing on technical approach, past performance, and team integration.
Department Of Defense

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 541714
New
Federal
NSF X-Labs Initiative - From Sequence to Function
Solicitation # NSF-Topic4-FY26-XLabsSequence-to-Function
The National Science Foundation Directorate for Technology, Innovation and Partnerships is soliciting written proposals for the NSF X-Labs initiative, specifically focusing on the bioengineering technical domain from sequence to function. This opportunity is issued under the Other Transactions Agreement Solutions Offering and utilizes Other Transaction contracts pursuant to 42 U.S.C 19116, meaning it is neither a FAR-based procurement nor a financial assistance instrument. The program is structured in phases, beginning with Phase 0, which lasts approximately 9 to 12 months starting in September 2027, followed by a potential Phase 1 lasting 24 to 36 months starting in June 2028. All work must be performed within the United States. The selection process is a two-step competitive evaluation consisting of a written proposal and a subsequent oral presentation for selected teams. Proposals are evaluated based on team qualifications, structure, mission clarity, and outcomes. Lead organizations must be registered in the System for Award Management and provide a Unique Entity Identifier. Due to the nature of the bioengineering domain, teams must provide specific plans for biosafety and biosecurity, including assessments of dangerous gain-of-function. Awards are milestone-based, with payments scheduled quarterly upon the successful completion of documented technical exit criteria. Organizational Conflicts of Interest are managed using FAR Subpart 9.5 as a framework, requiring full disclosure of any potential conflicts to the Agreements Officer Representative. Written proposals must be submitted as PDFs via the NSF submission portal by February 8, 2027.
Tip - Core Programs

POSTED

1 day ago

DEADLINE

in 4 months
View Details